These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17274058)

  • 1. Salivary glutathione and uric acid levels in patients with head and neck squamous cell carcinoma.
    Almadori G; Bussu F; Galli J; Limongelli A; Persichilli S; Zappacosta B; Minucci A; Paludetti G; Giardina B
    Head Neck; 2007 Jul; 29(7):648-54. PubMed ID: 17274058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD44 is a potential marker for the early detection of head and neck cancer.
    Franzmann EJ; Reategui EP; Pedroso F; Pernas FG; Karakullukcu BM; Carraway KL; Hamilton K; Singal R; Goodwin WJ
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1348-55. PubMed ID: 17627000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of folate, homocysteine, and vitamin B12 in head and neck squamous cell carcinoma and in laryngeal leukoplakia.
    Almadori G; Bussu F; Galli J; Cadoni G; Zappacosta B; Persichilli S; Minucci A; Giardina B; Maurizi M
    Cancer; 2005 Jan; 103(2):284-92. PubMed ID: 15593092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma glutathione S-transferase P1-1 levels in patients with head and neck squamous cell carcinoma.
    Oude Ophuis MB; Mulder TP; Peters WH; Manni JJ
    Cancer; 1998 Jun; 82(12):2434-8. PubMed ID: 9635537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary antioxidants in patients with type 1 or 2 diabetes and inflammatory periodontal disease: a case-control study.
    Gümüş P; Buduneli N; Cetinkalp S; Hawkins SI; Renaud D; Kinane DF; Scott DA
    J Periodontol; 2009 Sep; 80(9):1440-6. PubMed ID: 19722794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary soluble CD44: a potential molecular marker for head and neck cancer.
    Franzmann EJ; Reategui EP; Carraway KL; Hamilton KL; Weed DT; Goodwin WJ
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):735-9. PubMed ID: 15767360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species, and antioxidant profile.
    Bahar G; Feinmesser R; Shpitzer T; Popovtzer A; Nagler RM
    Cancer; 2007 Jan; 109(1):54-9. PubMed ID: 17099862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.
    Farshadpour F; Hordijk GJ; Koole R; Slootweg PJ
    J Oral Pathol Med; 2008 Oct; 37(9):549-54. PubMed ID: 18331287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
    Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
    Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
    Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic significance of adenosine deaminase, uric acid and C-reactive protein levels in patients of head and neck carcinoma.
    Dhankhar R; Dahiya K; Sharma TK; Ghalaut VS; Atri R; Kaushal V
    Clin Lab; 2011; 57(9-10):795-8. PubMed ID: 22029199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
    Carvalho AL; Jeronimo C; Kim MM; Henrique R; Zhang Z; Hoque MO; Chang S; Brait M; Nayak CS; Jiang WW; Claybourne Q; Tokumaru Y; Lee J; Goldenberg D; Garrett-Mayer E; Goodman S; Moon CS; Koch W; Westra WH; Sidransky D; Califano JA
    Clin Cancer Res; 2008 Jan; 14(1):97-107. PubMed ID: 18172258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
    Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
    J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced lipid peroxidation and nitric oxide products with deranged antioxidant status in patients with head and neck squamous cell carcinoma.
    Rasheed MH; Beevi SS; Geetha A
    Oral Oncol; 2007 Apr; 43(4):333-8. PubMed ID: 16857409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagen sensitivity of patients with cancer at different sites of the head and neck.
    Székely G; Remenár E; Kásler M; Gundy S
    Mutagenesis; 2005 Sep; 20(5):381-5. PubMed ID: 16105906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statherin levels in saliva of patients with precancerous and cancerous lesions of the oral cavity: a preliminary report.
    Contucci AM; Inzitari R; Agostino S; Vitali A; Fiorita A; Cabras T; Scarano E; Messana I
    Oral Dis; 2005 Mar; 11(2):95-9. PubMed ID: 15752082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma.
    Ohshiro K; Rosenthal DI; Koomen JM; Streckfus CF; Chambers M; Kobayashi R; El-Naggar AK
    Int J Oncol; 2007 Mar; 30(3):743-9. PubMed ID: 17273777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saliva as a biomarker for head and neck squamous cell carcinoma: in vitro detection of cytotoxic effects by using the plating efficiency index.
    Bloching MB; Barnes J; Aust W; Knipping S; Neumann K; Grummt T; Naim R
    Oncol Rep; 2007 Dec; 18(6):1551-6. PubMed ID: 17982643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.
    Righini CA; de Fraipont F; Timsit JF; Faure C; Brambilla E; Reyt E; Favrot MC
    Clin Cancer Res; 2007 Feb; 13(4):1179-85. PubMed ID: 17317827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased sensitivity to bleomycin in upper aerodigestive tract mucosa of head and neck squamous cell carcinoma patients.
    Jin C; Jin Y; Wennerberg J; Rosenquist B; Mertens F
    Mutat Res; 2008 Mar; 652(1):30-7. PubMed ID: 18243046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.